There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shockwave Medical (SWAV – Research Report), Veeva Systems (VEEV – Research Report) and Legend Biotech (LEGN – Research Report) with bullish sentiments.
Shockwave Medical (SWAV)
Piper Sandler analyst Adam Maeder maintained a Buy rating on Shockwave Medical today and set a price target of $360.00. The company’s shares closed last Monday at $320.51, close to its 52-week high of $331.58.
According to TipRanks.com, Maeder is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Shockwave Medical with a $276.71 average price target, implying a -14.9% downside from current levels. In a report issued on March 27, C.L. King also initiated coverage with a Buy rating on the stock with a $368.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Veeva Systems (VEEV)
Piper Sandler analyst Brent Bracelin maintained a Buy rating on Veeva Systems today and set a price target of $245.00. The company’s shares closed last Monday at $230.39, close to its 52-week high of $236.90.
According to TipRanks.com, Bracelin is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Veeva Systems with a $240.26 average price target, which is a 4.0% upside from current levels. In a report issued on March 25, Oppenheimer also maintained a Buy rating on the stock with a $260.00 price target.
Legend Biotech (LEGN)
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Legend Biotech, with a price target of $90.00. The company’s shares closed last Monday at $57.22.
According to TipRanks.com, Tenthoff is a 4-star analyst with an average return of
Currently, the analyst consensus on Legend Biotech is a Strong Buy with an average price target of $86.83, representing a 51.4% upside. In a report issued on March 18, H.C. Wainwright also reiterated a Buy rating on the stock with a $87.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SWAV:
